tradingkey.logo

Billiontoone Announces Selection Of Northstar Select® As The New Liquid Biopsy Test

ReutersJan 6, 2026 3:11 PM

- BillionToOne Inc BLLN.O:

  • BILLIONTOONE ANNOUNCES SELECTION OF NORTHSTAR SELECT® AS THE NEW LIQUID BIOPSY TEST FOR LC-SCRUM-TRY CLINICAL STUDY AT NATIONAL CANCER CENTER HOSPITAL EAST

  • BILLIONTOONE- ULTRA-SENSITIVE LIQUID BIOPSY EXPANDING PRECISION MEDICINE ACCESS IN JAPAN WITH TREATMENT-RESISTANT NON-SMALL CELL LUNG CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI